Valuation
Is the price right?2/2 inputs reported · High confidence
Weaker than most peers on:
- ▼ P/B
- ▼ Earnings yield
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Nov 1, 2026
2/2 inputs reported · High confidence
Weaker than most peers on:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Why it changed since the Oct 27, 2026 close: Score 64 → 65
Stronger than most peers on:
Earnings-per-share growth versus other banks and insurers.
2/2 inputs reported · High confidence
Stronger than most peers on:
Return on equity and return on assets versus other banks and insurers.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Got stronger
| Previous year | Latest year | Change | |
|---|---|---|---|
| Revenue (12 months) | 27.5B PEN | 28.6B PEN | +3.9% |
| Net income (12 months) | 5.5B PEN | 6.9B PEN | +25.9% |
| Free cash flow (12 months) | 14.2B PEN | 8.3B PEN | −41.4% |
| Cash | 47.6B PEN | 49.0B PEN | +3.0% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one year at a time.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Net margin | 18.4% | 22.2% | 19.0% | 20.0% | 24.3% | ▲ 4.2 pts |
| Return on assets (ROA) | 1.5% | 2.0% | 2.0% | 2.1% | 2.6% | ▲ 0.4 pts |
| Return on equity (ROE) | 13.6% | 16.0% | 15.0% | 16.0% | 18.1% | ▲ 2.0 pts |
Price history is added with the daily price update and will appear after the next one.